Comments

Beam Therapeutics Stock Guidance

BEAMNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$27.09
-0.27-0.97%
Last update: Dec 15, 10:22 AM
OverviewNewsEarningsOptionsDividendsAnalyst RatingsInsider TradesShort InterestStock Report

Beam Therapeutics Stock Guidance | NASDAQ:BEAM | Benzinga

Beam Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
Beam Therapeutics Inc (BEAM) does not provide guidance data

FAQ

Q

What is the most recent guidance for Beam Therapeutics (BEAM)?

A

There have been no specific sales or earnings guidance reported for Beam Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

IDEAYA Biosciences Inc
NASDAQ:IDYA
$34.07
%
Sarepta Therapeutics Inc
NASDAQ:SRPT
$21.03
-2.35%
Ascentage Pharma Group International
NASDAQ:AAPG
$30.35
%
No data available
Mesoblast Ltd
NASDAQ:MESO
$17.64
-2.38%
Kiniksa Pharmaceuticals International PLC
NASDAQ:KNSA
$41.35
0.02%
Olema Pharmaceuticals inc
NASDAQ:OLMA
$33.40
6.91%
Nurix Therapeutics Inc
NASDAQ:NRIX
$18.80
-1.42%
Dyne Therapeutics Inc
NASDAQ:DYN
$19.31
0.23%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved